Abstract

BackgroundExosomes are emerging as important mediators of the cross-talk between tumor cells and the microenvironment. The communication between tumor-derived exosomes and macrophages has a critical role in facilitating tumor progression. However, the mechanisms by which exosomes modulate tumor development in lung cancer are not fully understood.MethodsShort hairpin RNA mediated knockdown or exogenous expression of TRIM59 combined with in vitro and in vivo assays were performed to prove the functional significance of TRIM59. Western blotting, real-time PCR, co-immunoprecipitation, immunofluorescence (IF) staining assays, proximity ligation assay (PLA), ubiquitination assays, lactate secretion and lipid droplets content measurement, and rescue experiments were used to evaluate the mechanism. Lewis lung carcinoma (LLC) cells were injected via subcutaneously or tail vein into C57BL/6 wild-type (WT) and transgenic mice to assess the role of TRIM59 in vivo.ResultsWe demonstrated that tripartite motif-containing 59 (TRIM59) was expressed in lung cancer cells-derived exosomes, and can be transferred to macrophages through the exosomes. Activated macrophages by TRIM59 promote lung cancer progression in vitro and in vivo. Mechanistic investigations revealed that TRIM59 physically interacts with abhydrolase domain containing 5 (ABHD5) and directly induced the ubiquitination of ABHD5 and led to its proteasome-dependent degradation. ABHD5, an lipolytic co-activator, deficiency induced metabolic reprogramming and enabled NLRP3 inflammasome activation in macrophages. Further studies showed that the exacerbation of NLRP3 inflammasome activation by ABHD5 deficiency, provides a positive feedback loop to promote cancer progression by preferentially secrete the proinflammatory cytokine IL-1β.ConclusionsCollectively, these data indicate that tumor-derived exosomal TRIM59 converts macrophages to tumor-promoting functions of macrophages via regulating ABHD5 proteasomal degradation, to activate NLRP3 inflammasome signaling pathway to promote lung cancer progression by IL-1β secretion. Our findings also indicate that tumor-derived exosomal TRIM59 has an important role in intercellular communication for fostering an inflammatory microenvironment and promoting lung metastasis.

Highlights

  • Exosomes are emerging as important mediators of the cross-talk between tumor cells and the microenvironment

  • Our findings indicate that tumor-derived exosomal tripartite motif-containing 59 (TRIM59) has an important role in intercellular communication for fostering an inflammatory microenvironment and promoting lung metastasis

  • Results showed that macrophages incubated with exosomes derived from H1299 and A549 cells (ExoTRIM59+) had higher TRIM59 level than that with exosomes derived from TRIM59-knockout H1299 and A549 cells (ExoTRIM59−) in a time-dependent and concentration-dependent manner (Fig. 1e, f, Figure S1E, F). These results clearly demonstrated that TRIM59 is expressed in lung cancer cells-derived exosomes, and can be transferred to macrophages through the exosomes

Read more

Summary

Introduction

Exosomes are emerging as important mediators of the cross-talk between tumor cells and the microenvironment. The mechanisms by which exosomes modulate tumor development in lung cancer are not fully understood. Immune evasion represents a hallmark of cancer [4]. The majority of cancer immunotherapies, including immune checkpoint blockade therapy, aim to counteract immune evasion by shifting the balance in favor of immune activation, enabling T cell-mediated cancer cell elimination [4, 5]. Only a subset of patients benefit from immunotherapies, emphasizing the need to identify the genomic and molecular determinants underpinning immune evasion [6]. The discovery of new diagnostic biomarkers and a better understanding of molecular mechanisms underlying the tumor microenvironment of lung cancer are crucial

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.